Clonal Progression of Prostate Cancers from Gleason Grade 3 to Grade 4

Por Sowalsky, Adam G., Ye, Huihui, Bubley, Glenn J., Balk, Steven P.
Publicado em 2012

Androgen receptor phosphorylation and stabilization in prostate cancer by cyclin-dependent kinase 1

Por Chen, Shaoyong, Xu, Youyuan, Yuan, Xin, Bubley, Glenn J., Balk, Steven P.
Publicado em 2006

Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium

Por Stanbrough, Michael, Leav, Irwin, Kwan, Paul W. L., Bubley, Glenn J., Balk, Steven P.
Publicado em 2001

Whole Transcriptome Sequencing Reveals Extensive Unspliced mRNA in Metastatic Castration-Resistant Prostate Cancer

Por Sowalsky, Adam G., Xia, Zheng, Wang, Liguo, Zhao, Hao, Chen, Shaoyong, Bubley, Glenn J., Balk, Steven P., Li, Wei
Publicado no Mol Cancer Res (2014)

Hypoxia-inducible factor-2α: effect on radiation sensitivity and differential regulation by an mTOR inhibitor

Por Bhatt, Rupal S., Landis, Daniel M., Zimmer, Michael, Torregrossa, Joelle, Chen, Shaoyong, Sukhatme, Vikas P., Iliopoulos, Othon, Balk, Steve, Bubley, Glenn J.
Publicado em 2008

Androgen Receptor Remains Critical for Cell-Cycle Progression in Androgen-Independent CWR22 Prostate Cancer Cells

Por Yuan, Xin, Li, Tong, Wang, Hongyun, Zhang, Tao, Barua, Moumita, Borgesi, Robert A., Bubley, Glenn J., Lu, Michael L., Balk, Steven P.
Publicado em 2006

Tyrosine Kinases Expressed in Vivo by Human Prostate Cancer Bone Marrow Metastases and Loss of the Type 1 Insulin-Like Growth Factor Receptor

Por Chott, Andreas, Sun, Zijie, Morganstern, Daniel, Pan, Jing, Li, Tong, Susani, Martin, Mosberger, Isabella, Upton, Melissa P., Bubley, Glenn J., Balk, Steven P.
Publicado em 1999

Eastern Cooperative Oncology Group Phase II Trial of Lapatinib in Men with Biochemically Relapsed, Androgen Dependent Prostate Cancer

Por Liu, Glenn, Chen, Yu-Hui, Kolesar, Jill, Huang, Wei, DiPaola, Robert, Pins, Michael, Carducci, Michael, Stein, Mark, Bubley, Glenn J., Wilding, George
Publicado em 2011

Detection of TMPRSS2-ERG Fusion Gene Expression in Prostate Cancer Specimens by a Novel Assay using Branched DNA

Por Lu, Bin, Maqsodi, Botoul, Yang, Wen, McMaster, Gary K, Perner, Sven, Regan, Meredith, Bubley, Glenn J, Balk, Steven P, Rubin, Mark, Sanda, Martin G.
Publicado em 2009

Intratumoral De Novo Steroid Synthesis Activates Androgen Receptor in Castration Resistant Prostate Cancer and is Upregulated by Treatment with CYP17A1 Inhibitors

Por Cai, Changmeng, Chen, Sen, Ng, Patrick, Bubley, Glenn J., Nelson, Peter S., Mostaghel, Elahe A., Marck, Brett, Matsumoto, Alvin M., Simon, Nicholas I., Wang, Hongyun, Chen, Shaoyong, Balk, Steven P.
Publicado em 2011

Phase II Study of Abiraterone Acetate Plus Prednisone in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer Demonstrating Radiographic Flare Discordant With Serolog...

Por Ryan, Charles J., Shah, Shreya, Efstathiou, Eleni, Smith, Matthew R., Taplin, Mary-Ellen, Bubley, Glenn J., Logothetis, Christopher J., Kheoh, Thian, Kilian, Christine, Haqq, Chris, Molina, Arturo, Small, Eric J.
Publicado em 2011

A National Multicenter Phase 2 Study of Prostate-specific Antigen (PSA) Pox Virus Vaccine with Sequential Androgen Ablation Therapy in Patients with PSA Progression: ECOG 9802

Por DiPaola, Robert S., Chen, Yu-Hui, Bubley, Glenn J., Stein, Mark N., Hahn, Noah M., Carducci, Michael A., Lattime, Edmund C., Gulley, James, Arlen, Philip M., Butterfield, Lisa H., Wilding, George
Publicado no Eur Urol (2014)

Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC-CP): Development and Validation of a Practical Health-Related Quality of Life Instrument for Use in the Routine...

Por Chang, Peter, Szymanski, Konrad M., Dunn, Rodney L., Chipman, Jonathan J., Litwin, Mark S., Nguyen, Paul L., Sweeney, Christopher J., Cook, Robert, Wagner, Andrew A., DeWolf, William C., Bubley, Glenn J., Funches, Renee, Aronovitz, Joseph A., Wei, John T., Sanda, Martin G.
Publicado em 2011

A phase II trial of abiraterone combined with dutasteride for men with metastatic castration-resistant prostate cancer

Por McKay, Rana R., Werner, Lillian, Mostaghel, Elahe A., Lis, Rosina, Voznesensky, Olga, Zhang, Zhenwei, Marck, Brett T., Matsumoto, Alvin M., Domachevsky, Liran, Zukotynski, Katherine A., Bhasin, Manoj, Bubley, Glenn J., Montgomery, Bruce, Kantoff, Philip W., Balk, Steven P., Taplin, Mary-Ellen
Publicado no Clin Cancer Res (2016)

Abiraterone Treatment in Castration-Resistant Prostate Cancer Selects for Progesterone Responsive Mutant Androgen Receptors

Por Chen, Eddy J., Sowalsky, Adam G., Gao, Shuai, Cai, Changmeng, Voznesensky, Olga, Schaefer, Rachel, Loda, Massimo, True, Lawrence D., Ye, Huihui, Troncoso, Patricia, Lis, Rosina L., Kantoff, Philip W., Montgomery, Robert B., Nelson, Peter S., Bubley, Glenn J., Balk, Steven P., Taplin, Mary-Ellen
Publicado no Clin Cancer Res (2014)

Phase II Multicenter Study of Abiraterone Acetate Plus Prednisone Therapy in Patients With Docetaxel-Treated Castration-Resistant Prostate Cancer

Por Danila, Daniel C., Morris, Michael J., de Bono, Johann S., Ryan, Charles J., Denmeade, Samuel R., Smith, Matthew R., Taplin, Mary-Ellen, Bubley, Glenn J., Kheoh, Thian, Haqq, Christopher, Molina, Arturo, Anand, Aseem, Koscuiszka, Michael, Larson, Steve M., Schwartz, Lawrence H., Fleisher, Martin, Scher, Howard I.
Publicado em 2010

Phase II Study of Androgen Synthesis Inhibition with Ketoconazole, Hydrocortisone, and Dutasteride in Asymptomatic Castration-Resistant Prostate Cancer

Por Taplin, Mary-Ellen, Regan, Meredith M., Ko, Yoo-Joung, Bubley, Glenn J., Duggan, Stephen E., Werner, Lillian, Beer, Tomasz M., Ryan, Christopher W., Mathew, Paul, Tu, Shi-Ming, Denmeade, Samuel R., Oh, William K., Sartor, Oliver, Mantzoros, Christos S., Rittmaster, Roger, Kantoff, Philip W., Balk, Steven P.
Publicado em 2009

Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials W...

Por Scher, Howard I., Halabi, Susan, Tannock, Ian, Morris, Michael, Sternberg, Cora N., Carducci, Michael A., Eisenberger, Mario A., Higano, Celestia, Bubley, Glenn J., Dreicer, Robert, Petrylak, Daniel, Kantoff, Philip, Basch, Ethan, Kelly, William Kevin, Figg, William D., Small, Eric J., Beer, Tomasz M., Wilding, George, Martin, Alison, Hussain, Maha
Publicado em 2008

Double-Blind, Randomized Trial of Docetaxel Plus Vandetanib Versus Docetaxel Plus Placebo in Platinum-Pretreated Metastatic Urothelial Cancer

Por Choueiri, Toni K., Ross, Robert W., Jacobus, Susanna, Vaishampayan, Ulka, Yu, Evan Y., Quinn, David I., Hahn, Noah M., Hutson, Thomas E., Sonpavde, Guru, Morrissey, Stephanie C., Buckle, Geoffrey C., Kim, William Y., Petrylak, Daniel P., Ryan, Christopher W., Eisenberger, Mario A., Mortazavi, Amir, Bubley, Glenn J., Taplin, Mary-Ellen, Rosenberg, Jonathan E., Kantoff, Philip W.
Publicado em 2012

Intense Androgen-Deprivation Therapy With Abiraterone Acetate Plus Leuprolide Acetate in Patients With Localized High-Risk Prostate Cancer: Results of a Randomized Phase II Neoadju...

Por Taplin, Mary-Ellen, Montgomery, Bruce, Logothetis, Christopher J., Bubley, Glenn J., Richie, Jerome P., Dalkin, Bruce L., Sanda, Martin G., Davis, John W., Loda, Massimo, True, Lawrence D., Troncoso, Patricia, Ye, Huihui, Lis, Rosina T., Marck, Brett T., Matsumoto, Alvin M., Balk, Steven P., Mostaghel, Elahe A., Penning, Trevor M., Nelson, Peter S., Xie, Wanling, Jiang, Zhenyang, Haqq, Christopher M., Tamae, Daniel, Tran, NamPhuong, Peng, Weimin, Kheoh, Thian, Molina, Arturo, Kantoff, Philip W.
Publicado no J Clin Oncol (2014)